With another earnings season upon us, The Fool's health care team is busy making sure investors know what to expect from their favorite companies this quarter, while also keeping with the Foolish approach of long-term investing.

In this segment, health care bureau chief Brenton Flynn runs through the upcoming earnings from Johnson & Johnson (NYSE:JNJ), which will be reporting Tuesday morning.

Brenton Flynn has no position in any stocks mentioned. The Motley Fool recommends Johnson & Johnson. The Motley Fool owns shares of Johnson & Johnson. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.